The second annual conference of International ovarian cancer consortium and the symposium on tumor microenvironment and therapeutic resistance
Ciro Isidoro1, Yong Sang Song2, Young-Joon Surh3, Danny N. Dhanasekaran4
1 Università del Piemonte Orientale, Department of Health Sciences, Via P. Solaroli 17, Novara, Italy
2 Cancer Research Institute, Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea
3 Tumor Microenvironment Global Core Research Center, College of Pharmacy, Seoul National University, Seoul, Korea
4 Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA
Correspondence:
Danny N. Dhanasekaran, email:
Correspondence:
Ciro Isidoro, email:
Keywords: ovarian cancer, tumor microenvironment, therapy resistance, oncogenes, drug discovery
Received: January 22, 2016 Accepted: February 07, 2016 Published: February 16, 2016
Abstract
The second Annual Meeting of the International Ovarian Cancer Consortium (IOCC) was held in conjunction with the Symposium on Tumor Microenvironment and Therapeutic Resistance at the Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, and USA. A brief welcoming event along with the banquet on Aug 16th was followed by the eight thematic scientific sessions from August 16 to 18, 2015. Forty-three lectures, organized in eight sessions, were discussed in front of an audience of more than hundred attendees. Emphasis was put on oncogene signaling in cancer genesis and progression, new approaches in Precision Medicine and therapy of ovarian cancer, the role of tumor microenvironment in carcinogenesis, and preventive/curative potential of natural products. In this meeting-report, we highlight the findings and the perspectives in cancer biology and therapeutic strategies that emerged during the conference.
